Therapeutics Acquisition Corp.
Therapeutics Acquisition Corp. (RACA) is a publicly traded company in the Unknown sector. Across all available filings, 2 corporate insiders have executed 3 transactions totaling $2.1M, demonstrating a bullish sentiment with $2.1M in net insider flow. The most recent transaction on Jun 29, 2021 involved a purchase of 209,100 shares valued at $2.1M.
RACA Insider Activity Summary
Who Is Buying RACA Stock?
No significant insider buying has been recorded for RACA in the recent period.
Who Is Selling RACA Stock?
No significant insider selling has been recorded for RACA in the recent period.
Is Therapeutics Acquisition Corp. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for RACA is bullish with an Insider Alignment Score of 100/100 and a net flow of $2.1M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
RACA Frequently Asked Questions
Understanding RACA Insider Activity
Insider trading at Therapeutics Acquisition Corp. (RACA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 2 insiders are actively trading RACA stock, having executed 3 transactions in the past 90 days. The most active insider is Peter Kolchinsky (Executive), who has made 2 transactions totaling $11.0M.
Related Tools
Track Therapeutics Acquisition Corp. Insider Activity
Get notified when executives and directors at RACA file new Form 4 transactions